Systemic treatment in the rat with epidermal growth factor causes polycystic growth of the ovaries

被引:4
作者
Christiansen, JJ [1 ]
VinterJensen, L [1 ]
Nielsen, K [1 ]
机构
[1] AARHUS UNIV HOSP, DEPT CLIN BIOCHEM, AARHUS, DENMARK
关键词
growth factors; luteinizing cells; polycystic ovary syndrome;
D O I
10.1111/j.1699-0463.1996.tb00700.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: It has previously been suggested that epidermal growth factor (EGF) plays a role in the function of the ovary. We administered systemic EGF to assess the influence of EGF receptor stimulation on the morphology of the ovaries. Methods: Forty-eight female Wistar rats were allocated to five groups receiving EGF treatment (150 mu g/kg/day) for 0 (controls), 1, 2, 3 and 4 weeks. All rats were exactly 8 weeks at the start of the experiment and 12 weeks at sacrifice. The EGF was administered in the weeks prior to sacrifice. At sacrifice, the perfusion-fixed ovaries were removed and weighed, and the volumes of tissue components were quantified using stereology. Results: EGF administration increased the total weight of the ovaries from 129+/-18 mg in the controls to 158+/-29 mg (p<0.05) after one week. In subsequent weeks the total weight increased to 230+/-73 mg (p<0.001). The weight gain after one week of treatment was exclusively due to a fourfold increase in follicular cyst volume (p<0.01). In subsequent weeks the cyst volume was increased up to eightfold. After 2, 3 and 4 weeks of treatment the quantity of luteinizing cells was likewise increased by 70% (p<0.01). Conclusion: EGF administration causes the follicular cells to produce cysts and increases the quantity of luteinizing cells.
引用
收藏
页码:147 / 152
页数:6
相关论文
共 30 条
[1]   EPIDERMAL GROWTH-FACTOR RECEPTOR EXPRESSION IN NORMAL OVARIAN EPITHELIUM AND OVARIAN-CANCER .1. CORRELATION OF RECEPTOR EXPRESSION WITH PROGNOSTIC FACTORS IN PATIENTS WITH OVARIAN-CANCER [J].
BERCHUCK, A ;
RODRIGUEZ, GC ;
KAMEL, A ;
DODGE, RK ;
SOPER, JT ;
CLARKEPEARSON, DL ;
BAST, RC .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (02) :669-674
[2]  
CARPENTER G, 1990, HDB EXPT PHARM PEPTI, V2
[3]  
CARPENTER G, 1990, PEPTIDE GROWTH FACTO, V1, P69
[4]   DISTRIBUTION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN THE RAT OVARY [J].
CHABOT, JG ;
STARNAUD, R ;
WALKER, P ;
PELLETIER, G .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1986, 44 (02) :99-108
[5]  
DASILVA VA, 1991, J DEV PHYSIOL, V15, P303
[6]  
DORRINGTON J H, 1987, Steroids, V50, P411, DOI 10.1016/0039-128X(87)90028-6
[7]   POLYCYSTIC-OVARY-SYNDROME - INTERACTION OF FOLLICLE-STIMULATING-HORMONE AND POLYPEPTIDE GROWTH-FACTORS IN ESTRADIOL PRODUCTION BY HUMAN GRANULOSA-CELLS [J].
FRANKS, S ;
MASON, HD .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 40 (1-3) :405-409
[8]   EPIDERMAL GROWTH-FACTOR BINDING-SITES IN PORCINE GRANULOSA-CELLS AND THEIR REGULATION BY FOLLICLE-STIMULATING-HORMONE [J].
FUJINAGA, H ;
YAMOTO, M ;
NAKANO, R ;
SHIMA, K .
BIOLOGY OF REPRODUCTION, 1992, 46 (04) :705-709
[9]  
JONES PBC, 1982, J BIOL CHEM, V257, P1268
[10]   EXPRESSION OF THE GENES FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS LIGANDS IN PORCINE CORPORA-LUTEA [J].
KENNEDY, TG ;
BROWN, KD ;
VAUGHAN, TJ .
ENDOCRINOLOGY, 1993, 132 (04) :1857-1859